John Bencich
2014
In 2014, John Bencich earned a total compensation of $313.5K as Executive Vice President and Chief Financial Officer and Chief Operating Officer at OncoGenex Pharmaceuticals.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $18,512 |
| Option Awards | $93,328 |
| Salary | $118,269 |
| Stock Awards | $63,400 |
| Total | $313,509 |
Bencich received $118.3K in salary, accounting for 38% of the total pay in 2014.
Bencich also received $20K in bonus, $18.5K in non-equity incentive plan, $93.3K in option awards and $63.4K in stock awards.
Rankings
In 2014, John Bencich's compensation ranked 11,627th out of 13,032 executives tracked by ExecPay. In other words, Bencich earned more than 10.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,627 out of 13,032 | 11th |
Division Manufacturing | 4,445 out of 4,966 | 11th |
Major group Chemicals And Allied Products | 1,535 out of 1,686 | 9th |
Industry group Drugs | 1,243 out of 1,365 | 9th |
Industry In Vitro and In Vivo Diagnostic Substances | 62 out of 72 | 14th |
Source: SEC filing on September 21, 2017.
Bencich's colleagues
We found two more compensation records of executives who worked with John Bencich at OncoGenex Pharmaceuticals in 2014.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019